Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

Claudin 4 Protein-VLP (CLDN4) (AA 1-209)

This VLP Claudin 4 protein is produced in HEK-293 Cells.
Catalog No. ABIN7504302

Quick Overview for Claudin 4 Protein-VLP (CLDN4) (AA 1-209) (ABIN7504302)

Target

See all Claudin 4 (CLDN4) Proteins
Claudin 4 (CLDN4)

Protein Type

VLP

Origin

  • 10
  • 2
  • 2
Human

Source

  • 7
  • 2
  • 2
  • 1
  • 1
HEK-293 Cells

Purity

> 95 % as determined by HPLC
  • Protein Characteristics

    AA 1-209

    Purpose

    Human Claudin 4 Protein-VLP

    Sequence

    Met1-Val209

    Characteristics

    Recombinant Human Claudin 4 Protein-VLP is expressed from HEK293.It contains Met1-Val209.

    Sterility

    0.22 μm filtered

    Endotoxin Level

    Less than 1EU per μg by the LAL method.
  • Want other Options for this Protein ?

    !
    Discover Our Predefined Custom Proteins and Custom Protein Services!
    Product
    Expression System
    Conjugate
    Origin
    Price starts at
    Expression System HEK-293 Cells
    Conjugate His tag
    Origin Human
    Price starts at $16,231.82
    Expression System Cell-free protein synthesis (CFPS)
    Conjugate Strep Tag
    Origin Human
    Price starts at $15,754.29

    Your project requires further customization? Contact us and discover our custom protein solutions

  • Restrictions

    For Research Use only
  • Format

    Liquid

    Buffer

    Supplied as 0.22μm filtered solution in PBS, 300 mM L-Arginine ( pH 7.4). Notice: If you need it for immunization, Do Not use any adjuvant.

    Storage

    -80 °C

    Storage Comment

    Valid for 12 months from date of receipt when stored at -80°C.,Recommend to aliquot the protein into smaller quantities for optimal storage. Please minimize freeze-thaw cycles.

    Expiry Date

    12 months
  • Target

    Claudin 4 (CLDN4)

    Alternative Name

    Claudin 4

    Background

    Claudin-4 (CLDN4) is a key component of tight junctions (TJs) in epithelial cells. CLDN4 is overexpressed in many epithelial malignancies and correlates with cancer progression. Changes in CLDN4 expression have been associated with epigenetic factors (such as hypomethylation of promoter DNA), inflammation associated with infection and cytokines, and growth factor signaling. CLDN4 helps to maintain the tumor microenvironment by forming TJs and acts as a barrier to the entry of anticancer drugs into tumors.

    Molecular Weight

    23.31 kDa.

    UniProt

    O14493

    Pathways

    Hepatitis C
You are here:
Chat with us!